Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Active, not recruiting · NCT05078866 · Registry updated 2026-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients | Colorectal Neoplasms, Hereditary Nonpolyposis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Lynch syndrome, Neoplasms by Site, Nutritional and Metabolic Diseases, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, metabolic disease, neoplasm, rectal disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-03 | NCT05078866 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | United States | 263 |
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| M D Anderson Cancer Center | Houston | United States | 667 |
| University of Puerto Rico | San Juan | Puerto Rico | 10 |